Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Video
IQVIA Institute Year-in-Review 2024
Dec 18, 2024
This video from IQVIA Institute Executive Director Murray Aitken offers a look back at highlights of Institute activities in 2024, including reports and other publications, webinars, and symposia.
YOU MAY ALSO BE INTERESTED IN
Institute Report
Rethinking Clinical Trial Country Prioritization
Enabling agility through global diversification
Institute Report
Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios
This report from the IQVIA Institute reflects on the current state of the end-to-end environment for cell and gene therapies
Related solutions
Clinical Research & Development Solutions
